An expert panel of India's central drug authority reviewed Serum Institute's application for approval of Covishield as booster dose against COVID-19 on Friday.
from NDTV News - Special https://ift.tt/3rZxcwb
Friday, 10 December 2021
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment